PTEN ameliorates autoimmune arthritis through down-regulating STAT3 activation with reciprocal balance of Th17 and

Seung Hoon Lee1, Jin-Sil Park1, Jae-Kyung Byun1

  • 1The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea, Seoul, South Korea.

Scientific Reports
|October 7, 2016
PubMed

Insights

PTEN protein, regulated by p53, ameliorates autoimmune arthritis by inhibiting STAT3 activation and Th17 cell differentiation. Loss of p53 exacerbates arthritis, highlighting PTEN

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Signal transducer and activator of transcription 3 (STAT3) inactivation is a therapeutic strategy for autoimmune arthritis.
  • PTEN (phosphatase and tensin homolog) is a tyrosine phosphatase that inhibits STAT3 activation.
  • PTEN expression, regulated by p53, influences the balance between Th17 and Treg cells in autoimmune arthritis.

Purpose of the Study:

  • To investigate the role of p53-regulated PTEN in experimental autoimmune arthritis.
  • To determine if PTEN ameliorates arthritis by inhibiting STAT3 activation and modulating T cell differentiation.

Main Methods:

  • Overexpression of PTEN in a mouse model of collagen-induced arthritis (CIA).
  • Assessment of CIA severity, T cell activation, and Th17/Treg cell populations.
  • Evaluation of STAT3 activation in the context of p53 deficiency.

Main Results:

  • Systemic PTEN overexpression reduced CIA severity and STAT3 activity.
  • PTEN overexpression decreased T cell activation and modulated Th17/Treg cell balance.
  • p53 deficiency led to decreased PTEN expression, increased STAT3 activation, exacerbated arthritis, and dysregulated Th17/Treg populations.

Conclusions:

  • PTEN plays a protective role in autoimmune arthritis by inhibiting STAT3 activation and Th17 differentiation.
  • p53-mediated regulation of PTEN is crucial for controlling autoimmune arthritis.
  • Targeting the STAT3-modulatory activity of PTEN presents a potential therapeutic approach for rheumatoid arthritis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K